Khanyisani Ziqubu | Biochemistry | Young Scientist Award

Dr. Khanyisani Ziqubu | Biochemistry | Young Scientist Award

Dr. Khanyisani Ziqubu | Biochemistry | University of the Western Cape | South Africa

Dr. Khanyisani Ziqubu is a dedicated South African biochemist whose research focuses on metabolic health, oxidative stress, and inflammation. With a strong foundation in both in vitro and in vivo experimental models, he has significantly contributed to understanding obesity, type 2 diabetes, and related metabolic disorders. He holds a Ph.D. in Biochemistry from North-West University, where his work explored the effects of flavonoids on brown adipocyte secretome. Dr. Ziqubu’s research impact is reflected in his h-index of 22 and over 1,500 citations. His expertise spans molecular assays, mitochondrial bioenergetics, flow cytometry, next-generation chromatography, and advanced cell culture techniques. He has published extensively in high-impact journals and presented at notable international conferences. Beyond academia, Dr. Ziqubu actively engages in community science outreach programs, promoting health awareness and inspiring future scientists. His scientific rigor, teaching experience, and mentorship roles underscore his commitment to advancing biochemical research and improving public health outcomes.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Khanyisani Ziqubu’s academic journey began at the University of Zululand, where he earned a BSc in Biochemistry and Microbiology (2017). He continued with a BSc Honours in Biochemistry (2018), focusing on protein expression and co-expression systems in Escherichia coli. In 2020, he completed his MSc in Biochemistry, investigating the effects of isoorientin on fat browning in insulin-resistant cells. This work laid the foundation for his later focus on flavonoids and adipocyte function. His doctoral studies at North-West University, completed in 2025, delved into the brown adipocyte secretome and the role of flavonoids in regulating batokine secretion. These qualifications equipped him with advanced expertise in molecular biology, mitochondrial physiology, metabolic disease mechanisms, and analytical biochemistry. Throughout his education, Dr. Ziqubu demonstrated academic excellence, earning competitive scholarships and awards, while also gaining teaching and mentorship experience. His academic path reflects a sustained commitment to bridging molecular science with real-world health solutions.

Experience 

Dr. Khanyisani Ziqubu has cultivated a rich professional career blending research, teaching, and mentorship. He is currently a Postdoctoral Researcher at the University of the Western Cape (2025), specializing in cellular and molecular biochemistry. In 2024, he served as a Temporal Lecturer at North-West University, delivering advanced modules in cellular and molecular biology. From 2021 to 2023, he was a Student Assistant for introductory biochemistry, and earlier (2019–2020) he was a Junior Researcher in the South African Medical Research Council’s MSc Internship Programme. His teaching journey began as a Human Anatomy tutor at the University of Zululand (2017–2018). Dr. Ziqubu has supervised postgraduate research, guiding MSc and BSc Honours students to successful completion. His laboratory skills include working with rodent models, high-resolution respirometry, flow cytometry, and molecular assays. Additionally, he has participated in multiple community outreach initiatives, including diabetes awareness campaigns and science engagement showcases, underscoring his commitment to societal impact.

Awards and Honors 

Dr. Khanyisani Ziqubu’s scientific excellence has been recognized through multiple prestigious awards and fellowships. In 2024, he received the IUBMB-FAOBMB-ComBio Young Scientist Program Fellowship, a testament to his promising research contributions and potential for global impact. Between 2019 and 2023, he was a recipient of the South African Medical Research Council Internship Scholarship Programme, which supported his MSc and doctoral research. His presentation skills and innovative findings earned him the Early Career Scientist Best Presentation Award in 2019. Earlier in his academic career, in 2017, he was honored with the CSIR-DST Inter-Programme Award for research excellence and innovation. These accolades reflect not only his scholarly achievements but also his dedication to advancing biochemistry in South Africa and internationally. They highlight his capacity to conduct high-quality research, mentor upcoming scientists, and contribute meaningfully to the scientific community through both academic and community-centered initiatives.

Research Focus 

Dr. Khanyisani Ziqubu’s research centers on understanding the molecular and cellular mechanisms underlying metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). His work investigates how bioactive compounds particularly flavonoids modulate adipose tissue function, inflammation, oxidative stress, and mitochondrial bioenergetics. Using both in vitro cell culture and in vivo rodent models, he explores therapeutic strategies that target brown and beige adipose tissue to enhance metabolic health. He is skilled in advanced analytical techniques such as Seahorse XF metabolic flux analysis, Oroboros high-resolution respirometry, flow cytometry, molecular assays, and next-generation chromatography. His studies aim to bridge the gap between nutritional biochemistry and clinical interventions, providing mechanistic insights that could inform new treatments for metabolic diseases. Through his publications and conference presentations, Dr. Ziqubu contributes to global discussions on precision nutrition, functional foods, and targeted biochemical therapies for improving human health outcomes.

Publications 

  1. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress.

  2. Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis.

  3. Isoorientin: A dietary flavone with the potential to ameliorate diverse metabolic complications.

  4. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in metabolic disorders.

  5. Detrimental effects of lipid peroxidation in type 2 diabetes: Neutralizing influence of antioxidants.

  6. N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation.

  7. Brown/beige adipose tissue whitening: A metabolic complication of obesity.

  8. Antidiabetic properties of Moringa oleifera extracts focusing on oxidative stress and inflammation.

  9. Drug-induced liver injury: Clinical evidence of N-acetyl cysteine protective effects.

  10. Anti-obesity effects of metformin targeting brown adipose tissue.

  11. Adipokines as a therapeutic target by metformin: A systematic review.

  12. Aspalathin’s potential to reverse hepatic insulin resistance by improving mitochondrial respiration.

Conclusion

Dr. Khanyisani Ziqubu is a rising star in biochemistry, blending rigorous research, innovative methodologies, and impactful mentorship. His work on flavonoids, adipose tissue biology, and metabolic disease positions him as a key contributor to biomedical science. With significant publications, international recognition, and community engagement, he exemplifies the qualities of a leading biochemical researcher.

Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo, Universidad de Málaga, Spain

Dr. Maximino Redondo Bautista is an accomplished Spanish physician and professor, with an extensive career in clinical laboratory medicine and health research. Since 1993, he has served as a Medical Specialist at Hospital Universitario Costa del Sol in Málaga, while concurrently advancing academia as a full-time professor at the University of Málaga. With six recognized research sexennia and leadership of the hospital’s Research Unit, Dr. Redondo has made significant strides in translational medicine, oncology, and chronic disease studies. He has led 18 competitive research projects supported by the Instituto de Salud Carlos III and regional health bodies. His international collaborations and contributions to multicenter studies have shaped evidence-based healthcare practices in Spain. Through consistent involvement in national research networks like REDISSEC and RICAPPS, he promotes innovation, training, and the implementation of real-world healthcare solutions.

Profile

Google Scholar

🌟 Assessment of Suitability for the Research for Best Scholar Award: Dr. Maximino Redondo Bautista

Summary of Suitability:

Dr. Maximino Redondo Bautista stands as a highly qualified candidate for the Research for Best Scholar Award, bringing decades of academic, clinical, and research excellence to the forefront. With a strong dual appointment as a Medical Specialist at the Hospital Universitario Costa del Sol since 1993 and a Full Professor (Catedrático) at the University of Málaga since 2023, his contributions straddle both advanced medical practice and academic leadership.

Dr. Redondo earned his Doctorate in Medicine and Surgery from the University of Granada in 1991, along with specialized academic training in Epidemiology and Clinical Research. His professional journey reflects a consistent climb, with long-term involvement in academia and research, having held multiple professorial roles and received continuous competitive research funding. Over the years, he has served as Principal Investigator in 18 competitive research projects funded by the Instituto de Salud Carlos III and the Andalusian Health Council.

🎓 Education

Dr. Redondo holds a Doctorate in Medicine and Surgery from the University of Granada (1991), which laid the groundwork for his specialization in clinical analysis and translational medical research. He also earned a University Expert Degree in Epidemiology and Clinical Research from the same university in 2000. His academic journey began with a residency (MIR) in Clinical Analysis at the University Hospital Virgen de las Nieves (1986–1990), followed by key professional training in top Spanish medical centers. Over the years, he has cultivated a strong background in biomedical sciences and public health, supported by further academic certification and participation in national programs. His extensive formal education, complemented by teaching roles since 1992, has empowered him to nurture emerging scientists, shape academic curricula, and contribute to policy-oriented research in health sciences.

💼 Professional Experience

Dr. Maximino Redondo has more than three decades of experience in clinical medicine, research, and higher education. Since 1993, he has worked as a Clinical Laboratory Specialist at Hospital Universitario Costa del Sol. In academia, he has been a professor at the University of Málaga since 1992, most recently serving as Chair Professor in the Department of Surgical Specialties, Biochemistry, and Immunology. He also served as a Tenured Professor and Associate Professor over the years. His extensive career includes significant research leadership: serving on competitive programs at Instituto de Salud Carlos III and the Andalusian Health Council. He coordinates national research networks, leads clinical studies, and contributes to translational research initiatives. Dr. Redondo’s integrated professional approach bridges patient care, scientific inquiry, and academic excellence, shaping policy and fostering innovation in health service delivery.

🏅 Awards and Recognition 

Dr. Redondo has been widely recognized for his exceptional contributions to biomedical research, health policy, and academic mentorship. His work has earned six officially recognized sexenios de investigación (six-year research productivity periods), a distinguished mark in Spanish academia. He has led 18 competitive research projects and was repeatedly selected for national Intensification Programs by both Instituto de Salud Carlos III and the Andalusian Ministry of Health. Dr. Redondo played a central role in the REDISSEC and RICAPPS research networks, coordinating multicenter studies and leading national healthcare strategies. His efforts have translated research findings into impactful healthcare practices and evidence-based policy reforms. As a principal investigator and mentor, he has contributed to researcher training programs and advanced Spain’s health system through innovation and collaborative research. His influence spans medical education, diagnostics, and national public health frameworks.

🌍 Research Skills On Health Professions

Dr. Redondo excels in translational research, clinical epidemiology, biostatistics, and health services evaluation. His primary focus lies in oncology, chronic illness management, and the integration of research findings into real-world clinical practice. His skillset includes designing multicenter studies, applying evidence-based medicine, and leveraging laboratory diagnostics to inform health policies. As a senior researcher and group leader in the RICAPPS (RD21/0016/0015 and RD24/0005/0016) and REDISSEC networks, he coordinates collaborative research among hospitals, universities, and institutes across Spain. He also mentors early-career researchers, promotes interdisciplinary partnerships, and strengthens knowledge translation in healthcare. His ability to secure competitive funding and lead innovative health projects demonstrates scientific and managerial expertise. Dr. Redondo also contributes to editorial, evaluation, and strategic committees, ensuring the long-term sustainability and impact of research initiatives aimed at improving public health outcomes.

📖 Publication Top Notes

  • 🔬 Overexpression of clusterin in human breast carcinoma
    Authors: M. Redondo, E. Villar, J. Torres-Muñoz, T. Tellez, M. Morell, C.K. Petito
    Citation: The American Journal of Pathology, 157(2), 393–399.
    Year: 2000

  • 🧪 Immunotherapy: a challenge of breast cancer treatment
    Authors: M. García-Aranda, M. Redondo
    Citation: Cancers, 11(12), 1822.
    Year: 2019

  • 🧫 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
    Authors: C. Marchal, M. Redondo, M. Padilla, J. Caballero, I. Rodrigo, J. Garcia, et al.
    Citation: Histology and Histopathology, 2004.
    Year: 2004

  • 🧠 Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
    Authors: E. Matas-Rico, B. Garcia-Diaz, P. Llebrez-Zayas, D. López-Barroso, L. Santin, M. Redondo, et al.
    Citation: Molecular and Cellular Neuroscience, 39(3), 342–355.
    Year: 2008

  • 💉 Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy
    Authors: M. García-Aranda, E. Pérez-Ruiz, M. Redondo
    Citation: International Journal of Molecular Sciences, 19(12), 3950.
    Year: 2018

  • 🧬 Presence of HPV 16 sequences in laryngeal carcinomas
    Authors: M. Perez-Ayala, F. Ruiz-Cabello, F. Esteban, A. Concha, M. Redondo, et al.
    Citation: International Journal of Cancer, 46(1), 8–11.
    Year: 1990

  • 🧻 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Authors: M. Muñoz, R. Coveñas, F. Esteban, M. Redondo
    Citation: Journal of Biosciences, 40, 441–463.
    Year: 2015

  • 🫁 Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
    Authors: M. Redondo, A. Concha, R. Oldiviela, A. Cueto, A. Gonzalez, F. Garrido, et al.
    Citation: Cancer Research, 51(18), 4948–4954.
    Year: 1991

  • 🔬 NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
    Authors: M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, et al.
    Citation: Investigational New Drugs, 26, 111–118.
    Year: 2008

  • 🎯 Protein kinase targets in breast cancer
    Authors: M. García-Aranda, M. Redondo
    Citation: International Journal of Molecular Sciences, 18(12), 2543.
    Year: 2017